Probiotics and Their Role in the Management of Type 2 Diabetes Mellitus (Short-Term Versus Long-Term Effect): A Systematic Review and Meta-Analysis.

Autor:	Ayesha IE; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Monson NR; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Klair N; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Patel U; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Saxena A; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Patel D; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Venugopal S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Oct 09; Vol. 15 (10), pp. e46741. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).
DOI:	10.7759/cureus.46741
Abstrakt:	Diabetes is a major economic burden and an illness with a rising incidence worldwide. Type 2 diabetes mellitus (T2DM), the most prevalent kind of diabetes, is characterized by insulin resistance and insufficient insulin production. Recent research has implicated gut microbiota dysbiosis as a contributing factor to T2DM pathogenesis. The present study employed a methodology based on randomized controlled trials (RCTs) to assess the therapeutic efficacy of probiotics in the treatment of T2DM. A thorough search was done in PubMed and Medline for articles written in English and published between 2017 and 2023. Studies were chosen based on predetermined inclusion criteria, and the search technique adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) principles. This study also employed a robust assessment instrument, widely recognized in the medical and health sciences, to evaluate the potential presence of bias within the selected research studies. Out of 96 identified articles, 22 RCTs met the eligibility criteria. Both short-term (8 weeks or less) and long-term (12 weeks or more) probiotic administrations were made. The results of the meta-analysis demonstrated a significant improvement in the homeostatic model assessment of insulin resistance (HOMA-IR) following the probiotic intervention (P=0.02) and considerably decreased glycated hemoglobin HbA1c levels (P=0.004) and fasting blood glucose (FBG) levels (P<0.0001) in T2DM patients compared to placebo. This research offers proof that probiotics are clinically effective in the treatment of T2DM. Probiotic supplementation demonstrated favorable effects on glycemic control markers. However, the findings from RCTs were heterogeneous, and some studies showed inconsistent results. To clarify the processes underlying the probiotics' therapeutic benefits and to determine the best probiotic strains, doses, and therapy durations, more research is required. Nevertheless, probiotics offer a promising therapeutic approach for T2DM management and warrant consideration as a potential adjunct therapy in clinical practice. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Ayesha et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu